Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity

J Pediatr. 2018 Apr:195:16-27. doi: 10.1016/j.jpeds.2017.12.053.

Authors

Lauren M Pachman¹, Amer M Khojah²

Affiliations

¹ Department of Pediatrics , Northwestern University Feinberg School of Medicine, Chicago, IL; Stanley Manne Children's Research Institute, Cure JM Center of Excellence in Juvenile Myositis (JM) Research, Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
² Department of Pediatrics, Division of Pediatric Rheumatology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.

No abstract available

Keywords: pathophysiology; physical signs; treatment.

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Adult
Age of Onset
Autoantibodies / immunology*
Biomarkers / metabolism
Child
Dermatomyositis / epidemiology
Dermatomyositis / immunology*
Dermatomyositis / physiopathology
Dermatomyositis / therapy
Disease Progression
Female
Genetic Heterogeneity
Humans
Killer Cells, Natural / immunology
Male

Substances

Autoantibodies
Biomarkers

Grants and funding